Search
for
Sort by
Research 151–180 of 176
- Androgenetic Alopecia: a Review and Emerging Treatments
- Pharmacovigilance profiles of three generations of mineralocorticoid receptor antagonists and network toxicology analysis
- Update to acne vulgaris treatment for Canadian practice
- Pathophysiology, conventional treatments, and evidence-based herbal remedies of hair loss with a systematic review of controlled clinical trials
- Wokeness in Our Practice
- Patient-reported outcomes, provider-reported outcomes, and physiologic parameters after gender-affirming hormone treatment in Canada: a systematic review
- Real-World Experience of Clascoterone Cream 1% in Acne Management: Case Series and Canadian Experience
- ADRENOCORTICAL ADENOMA AS A CAUSE OF HYPERANDROGENISM SYNDROME IN A GIRL: THE PATH TO DIAGNOSIS
- Lip feminization: A review
- Report on the 11th National Congress AICPE (Associazione Italiana di Chirurgia Plastica Estetica) Held in Rimini, Italy, 12–14 April 2024
- The Biology and Genomics of Human Hair Follicles: A Focus on Androgenetic Alopecia
- Feminization Surgery of the Upper Face as the Crucial Factor in Gender Confirmation—Pearls and Pitfalls
- E-Poster
- Effects of Androgen Treatment on Growth in Patients with 5-α-Reductase Type 2 Deficiency
- Alternative androgen pathways
- The Transgender: Endocrinological Assessment
- Sex Differences in Opioid-Mediated Effects: Role of Androgens
- Outcome of Dutasteride 0.5mg in Androgenic Alopecia
- Toxicity of the pharmaceuticals finasteride and melengestrol acetate to benthic invertebrates
- Uterine transplantation in transgender women
- Hormonal Therapies for Individuals with Intersex Conditions
- Triclocarban, Triclosan, Bromochlorophene, Chlorophene, and Climbazole Effects on Nuclear Receptors: An <i>in Silico</i> and <i>in Vitro</i> Study
- Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?
- Management of transgender patients in critical care
- Body composition and physical fitness in transgender versus cisgender individuals: a systematic review with meta-analysis
- Dermatological care of gender‐diverse patients in Australia
- Disorders of sex development (DSD) 46.XY due to type 2 5-α reductase deficiency in three siblings: Case report from a low-resource setting
- Gender Reassignment
- 5-α-Reductase type 2 deficiency: is there a genotype-phenotype correlation? A review
- Facial determinants of female gender and feminizing forehead cranioplasty